Cargando…
Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia
INTRODUCTION: Chronological aging is a well-recognized diagnostic and prognostic factor in multiple cancer types, yet the role of biological aging in manifesting cancer progression has not been fully explored yet. METHODS: Given the central role of chronological aging in prostate cancer and AML inci...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512286/ https://www.ncbi.nlm.nih.gov/pubmed/37746266 http://dx.doi.org/10.3389/fonc.2023.1222168 |
_version_ | 1785108326800949248 |
---|---|
author | Ramakrishnan, Anitha Datta, Indrani Panja, Sukanya Patel, Harmony Liu, Yingci Craige, Michael W. Chu, Cassandra Jean-Marie, Giselle Oladoja, Abdur-Rahman Kim, Isaac Mitrofanova, Antonina |
author_facet | Ramakrishnan, Anitha Datta, Indrani Panja, Sukanya Patel, Harmony Liu, Yingci Craige, Michael W. Chu, Cassandra Jean-Marie, Giselle Oladoja, Abdur-Rahman Kim, Isaac Mitrofanova, Antonina |
author_sort | Ramakrishnan, Anitha |
collection | PubMed |
description | INTRODUCTION: Chronological aging is a well-recognized diagnostic and prognostic factor in multiple cancer types, yet the role of biological aging in manifesting cancer progression has not been fully explored yet. METHODS: Given the central role of chronological aging in prostate cancer and AML incidence, here we investigate a tissue-specific role of biological aging in prostate cancer and AML progression. We have employed Cox proportional hazards modeling to associate biological aging genes with cancer progression for patients from specific chronological aging groups and for patients with differences in initial cancer aggressiveness. RESULTS: Our prostate cancer-specific investigations nominated four biological aging genes (CD44, GADD45B, STAT3, GFAP) significantly associated with time to disease progression in prostate cancer in Taylor et al. patient cohort. Stratified survival analysis on Taylor dataset and validation on an independent TCGA and DKFZ PRAD patient cohorts demonstrated ability of these genes to predict prostate cancer progression, especially for patients with higher Gleason score and for patients younger than 60 years of age. We have further tested the generalizability of our approach and applied it to acute myeloid leukemia (AML). Our analysis nominated three AML-specific biological aging genes (CDC42EP2, CDC42, ALOX15B) significantly associated with time to AML overall survival, especially for patients with favorable cytogenetic risk score and for patients older than 56 years of age. DISCUSSION: Comparison of the identified PC and AML markers to genes selected at random and to known markers of progression demonstrated robustness of our results and nominated the identified biological aging genes as valuable markers of prostate cancer and AML progression, opening new avenues for personalized therapeutic management and potential novel treatment investigations. |
format | Online Article Text |
id | pubmed-10512286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105122862023-09-22 Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia Ramakrishnan, Anitha Datta, Indrani Panja, Sukanya Patel, Harmony Liu, Yingci Craige, Michael W. Chu, Cassandra Jean-Marie, Giselle Oladoja, Abdur-Rahman Kim, Isaac Mitrofanova, Antonina Front Oncol Oncology INTRODUCTION: Chronological aging is a well-recognized diagnostic and prognostic factor in multiple cancer types, yet the role of biological aging in manifesting cancer progression has not been fully explored yet. METHODS: Given the central role of chronological aging in prostate cancer and AML incidence, here we investigate a tissue-specific role of biological aging in prostate cancer and AML progression. We have employed Cox proportional hazards modeling to associate biological aging genes with cancer progression for patients from specific chronological aging groups and for patients with differences in initial cancer aggressiveness. RESULTS: Our prostate cancer-specific investigations nominated four biological aging genes (CD44, GADD45B, STAT3, GFAP) significantly associated with time to disease progression in prostate cancer in Taylor et al. patient cohort. Stratified survival analysis on Taylor dataset and validation on an independent TCGA and DKFZ PRAD patient cohorts demonstrated ability of these genes to predict prostate cancer progression, especially for patients with higher Gleason score and for patients younger than 60 years of age. We have further tested the generalizability of our approach and applied it to acute myeloid leukemia (AML). Our analysis nominated three AML-specific biological aging genes (CDC42EP2, CDC42, ALOX15B) significantly associated with time to AML overall survival, especially for patients with favorable cytogenetic risk score and for patients older than 56 years of age. DISCUSSION: Comparison of the identified PC and AML markers to genes selected at random and to known markers of progression demonstrated robustness of our results and nominated the identified biological aging genes as valuable markers of prostate cancer and AML progression, opening new avenues for personalized therapeutic management and potential novel treatment investigations. Frontiers Media S.A. 2023-09-06 /pmc/articles/PMC10512286/ /pubmed/37746266 http://dx.doi.org/10.3389/fonc.2023.1222168 Text en Copyright © 2023 Ramakrishnan, Datta, Panja, Patel, Liu, Craige, Chu, Jean-Marie, Oladoja, Kim and Mitrofanova https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Ramakrishnan, Anitha Datta, Indrani Panja, Sukanya Patel, Harmony Liu, Yingci Craige, Michael W. Chu, Cassandra Jean-Marie, Giselle Oladoja, Abdur-Rahman Kim, Isaac Mitrofanova, Antonina Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia |
title | Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia |
title_full | Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia |
title_fullStr | Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia |
title_full_unstemmed | Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia |
title_short | Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia |
title_sort | tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512286/ https://www.ncbi.nlm.nih.gov/pubmed/37746266 http://dx.doi.org/10.3389/fonc.2023.1222168 |
work_keys_str_mv | AT ramakrishnananitha tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT dattaindrani tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT panjasukanya tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT patelharmony tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT liuyingci tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT craigemichaelw tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT chucassandra tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT jeanmariegiselle tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT oladojaabdurrahman tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT kimisaac tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia AT mitrofanovaantonina tissuespecificbiologicalagingpredictsprogressioninprostatecancerandacutemyeloidleukemia |